Ap. Pharmamax SPRL
Ap. Pharmamax reported total assets of €1.09m at the end of the 2025 financial year (annual accounts filed with the NBB on 29 Sep 2026).
The score of Ap. Pharmamax shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +16 % Total assets +89 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Ap. Pharmamax's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 130,718 € | ||||
| Equity | 377,746 € | ||||
| Cash | 549,619 € | ||||
| EBITDA | 182,218 € | ||||
| Total assets | €1.09m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Sep 2026
- Year ended 31 Dec 2024filed on 04 Sep 2025
- Year ended 31 Dec 2023filed on 17 Dec 2024
- Year ended 31 Dec 2022filed on 18 Dec 2023
- Year ended 31 Dec 2021filed on 29 Sep 2022
Ap. Pharmamax's financial analysis
- Solvency34.8%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Ap. Pharmamax
Ap. Pharmamax's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0434.458.941
- VAT number
- BE0434458941
- Peppol
- Registered · 0208:0434458941 · as of 10 Nov 2026
- Legal form
- SPRL
- Incorporated
- 04 Jun 1988
- Registered office
- 2850 Boom
- Latest accounts
- 2025 · filed on 29 Sep 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Ap. Pharmamax (SPRL) has been based in Boom since 1988, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 130,718 € and equity of 377,746 €; its revenue is not published. Its solvency stands at 34.8%, below the median of its sector (44.2%).
Companies similar to Ap. Pharmamax
Companies in the same business, of comparable size and area, outside its group.
- Stediphar Retail sale of pharmaceutical products Ostend · balance sheet €1.09m
- Pharmacie Bauduin Retail sale of pharmaceutical products Brussels · balance sheet €1.09m
- Apotheek Sarah Haentjens Retail sale of pharmaceutical products Ronse · balance sheet €1.09m
- P. Corstiens Farma Retail sale of pharmaceutical products Westerlo · balance sheet €1.09m
- Assentfarma Retail sale of pharmaceutical products Bekkevoort · balance sheet €1.08m
- Fardil Retail sale of pharmaceutical products Dilbeek · balance sheet €1.10m
- Holsbeek Brasschaat Retail sale of pharmaceutical products Brasschaat · balance sheet €1.10m
- DE Maeyer Retail sale of pharmaceutical products Dilbeek · balance sheet €1.07m
Frequently asked questions about Ap. Pharmamax
What is the revenue of Ap. Pharmamax?
Ap. Pharmamax files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Ap. Pharmamax?
In Belgium, the VAT number is the company number prefixed with BE: BE0434458941 for Ap. Pharmamax, if the company is VAT-registered. Its company number (CBE) is 0434.458.941.
Where is the registered office of Ap. Pharmamax?
According to the CBE register, the registered office of Ap. Pharmamax is in 2850 Boom.
What is the equity of Ap. Pharmamax?
At the close of the 2025 financial year, the equity of Ap. Pharmamax amounts to 377,746 €, a solvency of 34.8% of total assets.
Who manages Ap. Pharmamax?
The register lists 2 active mandates at Ap. Pharmamax. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Ap. Pharmamax
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →